A case of Anti‐MDA5‐Positive dermatomyositis after inactivated COVID‐19 vaccine.

COVID-19 mRNA vaccine-associated dermatomyositis (DM) with the anti-TIF-1y-positive case was first reported in 2021.[2] Two reports about MDA5-DM patients after mRNA or adenovirus vector COVID-19 vaccines were searched out in the PubMed, Science Direct and SCOPUS by June 2022.[[3]] We first reported an MDA5-DM with rapid progressive interstitial lung disease (RP-ILD) patient after an inactivation COVID-19 vaccine, exhibiting time course of the disease development. Dear Editor, During the epidemic of COVID-19 disease worldwide, applying COVID-19 vaccination can effectively protect humans from serious symptoms and help reduce long-term effects.[1] However, COVID-19 vaccines have been linked to some potential side effects. A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine. [Extracted from the article]